Navidea Biopharmaceuticals Inc (NAVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NAVB | TMO | ISRG | ALC | DXCM |
| Company | Navidea Biopharmaceuticals Inc | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Alcon Inc | Dexcom Inc |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 0.0010 | 600.85 | 438.60 | 93.17 | 66.00 |
| High | 0.0010 | 614.65 | 446.16 | 94.22 | 67.44 |
| Low | 0.0010 | 599.30 | 432.87 | 92.99 | 62.34 |
| Last | 0.0010 | 607.14 | 441.30 | 93.37 | 64.00 |
| Change | unch | +12.64 | +4.56 | +1.53 | -43.85 |
| % Change | unch | +2.13% | +1.04% | +1.67% | -40.66% |
| Volume | 100 | 2,715,300 | 1,196,500 | 1,160,300 | 53,914,102 |
| 20-Day Average Volume | 16,315 | 1,872,945 | 1,855,750 | 866,670 | 5,353,530 |
| Previous Close | 0.0010 | 594.50 | 436.74 | 91.84 | 107.85 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0013 | 550.27 | 441.93 | 90.13 | 109.78 |
| 20-Day Raw Stochastic | 1.50% | 91.30% | 50.00% | 86.79% | 3.03% |
| 20-Day Relative Strength | 43.55% | 66.66% | 53.91% | 62.83% | 15.78% |
| Weighted Alpha | -58.59 | +13.83 | +42.01 | +17.27 | -36.91 |
| Today's Opinion | 100% Sell | 56% Buy | 88% Buy | 100% Buy | 88% Sell |
| Previous Opinion | 100% Sell | 56% Buy | 88% Buy | 100% Buy | 88% Sell |
| Last Month's Opinion | 100% Sell | 8% Buy | 100% Buy | 88% Buy | 72% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 07/18/24 | +13.62% since 07/19/24 | -3.01% since 07/19/24 | +3.73% since 07/19/24 | -42.68% since 07/19/24 |
| Low | 0.0010 on 07/26/24 | 535.98 on 07/22/24 | 432.87 on 07/26/24 | 89.98 on 07/23/24 | 62.34 on 07/26/24 |
| High | 0.0010 on 07/26/24 | 614.65 on 07/26/24 | 468.78 on 07/22/24 | 94.22 on 07/26/24 | 113.28 on 07/23/24 |
| 1-Month | |||||
| %Chg | +400.00% since 06/24/24 | +8.77% since 06/26/24 | -0.28% since 06/26/24 | +4.11% since 06/26/24 | -43.62% since 06/26/24 |
| Low | 0.0001 on 06/27/24 | 528.37 on 07/09/24 | 413.82 on 07/18/24 | 87.79 on 07/10/24 | 62.34 on 07/26/24 |
| High | 0.0100 on 07/15/24 | 614.65 on 07/26/24 | 468.78 on 07/22/24 | 94.22 on 07/26/24 | 117.19 on 07/17/24 |
| 3-Month | |||||
| %Chg | -97.38% since 04/26/24 | +5.85% since 04/26/24 | +17.58% since 04/26/24 | +18.53% since 04/26/24 | -48.53% since 04/26/24 |
| Low | 0.0001 on 06/27/24 | 528.37 on 07/09/24 | 367.39 on 05/02/24 | 77.54 on 04/30/24 | 62.34 on 07/26/24 |
| High | 0.0600 on 06/24/24 | 614.65 on 07/26/24 | 468.78 on 07/22/24 | 94.22 on 07/26/24 | 132.26 on 05/17/24 |
| 6-Month | |||||
| %Chg | -98.26% since 01/26/24 | +10.93% since 01/26/24 | +17.76% since 01/26/24 | +22.86% since 01/26/24 | -47.52% since 01/26/24 |
| Low | 0.0001 on 06/27/24 | 528.37 on 07/09/24 | 364.17 on 04/19/24 | 74.30 on 02/02/24 | 62.34 on 07/26/24 |
| High | 0.0600 on 06/24/24 | 614.65 on 07/26/24 | 468.78 on 07/22/24 | 94.22 on 07/26/24 | 142.00 on 03/26/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 100 | 231,755,056 | 156,529,104 | 46,040,752 | 25,451,776 |
| Shares Outstanding, K | 100,084 | 381,716 | 354,700 | 493,100 | 397,684 |
| Annual Sales | 70,000 | 42,857,000,000 | 7,124,100,000 | 9,455,000,000 | 3,622,300,000 |
| Annual Net Income | -15,180,000 | 5,995,000,000 | 1,798,000,000 | 974,000,000 | 541,500,000 |
| Last Quarter Sales | 0 | 10,345,000,000 | 2,009,900,000 | 2,459,000,000 | 921,000,000 |
| Last Quarter Net Income | -2,260,000 | 1,327,000,000 | 526,900,000 | 248,000,000 | 146,400,000 |
| 60-Month Beta | 1.50 | 0.77 | 1.39 | 0.97 | 1.16 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 11/14/23 | 5.37 on 07/24/24 | 1.78 on 07/18/24 | 0.78 on 05/13/24 | 0.43 on 07/25/24 |
| Latest Earnings Date | 08/09/24 | 07/24/24 | 07/18/24 | 08/20/24 | 07/25/24 |
| Most Recent Dividend | N/A | 0.390 on 06/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 09/13/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 27.22 | 87.88 | 32.45 | 61.63 |